MontgomeryAB, StagerMA, CarricoCJ, HudsonLD. Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Respir Dis. 1985;132:485–489.
ShoemakerWC, AppelP, CzerLSC, . Pathogenesis of respiratory failure (ARDS) after hemorrhage and trauma: I. Cardiorespiratory patterns preceding the development of ARDS. Crit Care Med. 1980;8:504–512.
4.
WeigeltJA, SnyderWHIII, MitchellRA. Early identification of patients prone to develop adult respiratory distress syndrome. Am J Surg. 1981;142:687–691.
5.
CalindrinoFSJr, AndersonDJ, MintunMA, SchusterDP. Pulmonary vascular permeability during the adult respiratory distress syndrome: A positron emission tomographic study. Am Rev Respir Dis. 1988;138:421–428.
6.
PinskyMR, MatuschakGM. Multiple systems organ failure: Failure of host defense homeostasis. Crit Care Clinic. 1989;5:199–220.
7.
FeinA, Weiner-KronishJP, NiedermanM, MatthayMA. Pathophysiology of the adult respiratory distress syndrome: What have we learned from human studies?Crit Care Clin. 1986;2:429–453.
8.
DemlingRH. The role of mediators in human ARDS. J Crit Care. 1988;3:56–72.
9.
HudsonLD. Multiple systems organ failure (MSOF): Lessons learned from the adult respiratory distress syndrome (ARDS). Crit Care Clinic. 1989;5:697–705.
10.
ThommasenHV. The role of the polymorphonuclear leukocyte in the pathogenesis of the adult respiratory distress syndrome. Clin Invest Med. 1985;8:185–194.
11.
TateRM, RepineJE. Neutrophils and the adult respiratory distress syndrome. Am Rev Respir Dis. 1983;128:552–559.
12.
RinaldoJE. Mediation of ARDS by leukocytes: Clinical evidence and implications for therapy. Chest. 1986;89:590–593.
13.
WeilandJE, DavisWB, HolterJF, MohammedJR, DorinskyPM, GadekJE. Lung neutrophils in the adult respiratory distress syndrome: Clinical and pathophysiologic significance. Am Rev Respir Dis. 1986;133:218–225.
BrighamKL. Mechanisms of lung injury. Clin Chest Med. 1982;3:9–24.
16.
WardPA, TillGO, HarherillJR, AnnesleyTM, KunkelRG. Systemic complement activation, lung injury, and products of lipid peroxidation. J Clin Invest. 1985;76:517–527.
17.
BrighamKL. Role of free radicals in lung injury. Chest. 1986;89:859–863.
18.
HammerschmidtDE, WeaverLJ, HudsonLD, . Association of complement activation and elevated plasma C5a with adult respiratory distress syndrome. Lancet. 1980;1:947–949.
19.
WeinbergPF, MatthayMA, WebsterRO, . Biologically active products of complement and acute lung injury in patients with the sepsis syndrome. Am Rev Respir Dis. 1984;130:791–796.
20.
DuchateauJ, HaasM, SchreyenH, . Complement activation in patients at risk of developing the adult respiratory distress syndrome. Am Rev Respir Dis. 1984;130:1058–1064.
21.
MaunderRJ, HarlanJM, TalucciRC, . Measurement of C3a and C5a in high-risk patients does not predict ARDS (abstract). Am Rev Respir Dis. 1984;129:A104.
22.
RubinDB, MatthayMA, WeinbergPF, MurrayJF. Factor VIII antigen: Possible plasma marker of progressive acute lung injury in patients with sepsis (abstract). Am Rev Respir Dis. 1985;131:A142.
23.
RobbinsR, MaunderR, GossmanG, KendallT, HudsonL, RennardS.Functional loss of chemotactic factor inactivator in the adult respiratory distress syndrome (abstract). Am Rev Respir Dis. 1986;133:A277.
24.
HudsonLD. Causes of the adult respiratory distress syndrome: Clinical recognition. Clin Chest Med. 1982;3:195–212.
25.
PepePE, PotkinRT, Holtman-ReusD, HudsonLD, CarricoCJ. Clinical predictors of the adult respiratory distress syndrome. Am J Surg. 1982;144:124–130.
26.
FowlerAA, HammanRF, GoodJT, . Adult respiratory distress syndrome: Risk with common predispositions. Ann Intern Med. 1983;98:593–597.
27.
PepePE, HudsonLD, CarricoCJ. Early application of positive end-expiratory pressure in patients at risk for the adult respiratory distress syndrome. N Engl J Med. 1984;311:281–286.
28.
MaunderRJ. Clinical prediction of the adult respiratory distress syndrome. Clin Chest Med. 1985;6:413–426.
29.
LuceJM, MontgomeryAB, MarksJD, . Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. Am Rev Respir Dis. 1988;138:62–68.
30.
DriksMR, CravenDE, CelliB, . Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. N Engl J Med. 1987;317:1376–1380.
31.
SchmidtGB, O'NeillWW, KotbK, KwangKK, BennetEJ, BoombeckCT. Continuous positive airway pressure in the prophylaxis of the adult respiratory distress syndrome. Surg Gynecol Obstet. 1976;143:613–618.
32.
WeigeltJA, MitchellRA, SnyderWHIII. Early positive end-expiratory pressure in the adult respiratory distress syndrome. Arch Surg. 1979;114:497–501.
33.
BellRC, CoalsonJJ, SmithJD, JohansonWGJr. Multiple organ failure and infection in adult respiratory distress syndrome. Ann Intern Med. 1983;99:293–298.
34.
SeidenfeldJJ, PohlDF, BellRC, HarrisGD, JohansonWGJr. Incidence, site, and outcome of infections in patients with the adult respiratory distress syndrome. Am Rev Respir Dis. 1986;134:12–16.
35.
GattinoniL, PesentiA, MascheroniD, . Low-frequency positive-pressure ventilation with extracorporeal CO2 removal in severe acute respiratory failure: Clinical results. JAMA. 1986;256:881–886.
36.
ZapolWM, SniderMT, DillJD, . Extracorporeal membrane oxygenation in severe acute respiratory failure. JAMA. 1979;242:2193–2196.
37.
MorrisAH, MenloveRL, RollinsRJ, WallaceCJ, BeckE.A controlled clinical trial of a new 3-step therapy that includes extracorporeal CO2 removal for ARDS. Trans Am Soc Artif Organs. 1988;34:48–53.
38.
GurevitchMJ, VanDykeJV, YoungES, JacksonK.Improved oxygenation and lower peak airway pressure in severe adult respiratory distress syndrome: Treatment with inverse ratio ventilation. Chest. 1986;89:211–213.
39.
Collaborative European Multicenter Study Group. Surfactant replacement therapy for severe neonatal respiratory distress syndrome: An international randomized clinical trial. Pediatrics. 1988;82:683–691.
40.
HorbarJD, SollRF, SutherlandJM, . A multicenter randomized placebo-controlled trial of surfactant therapy for respiratory distress syndrome. N Engl J Med. 1989;320:959–965.
41.
StrayerDS, MerrittTA, MakunikeC, HallmanM.Antigenicity of low molecular weight surfactant species. Am J Pathol. 1989;134:723–732.
42.
BernardGR, LuceJM, SprungCL, . High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med. 1987;317:1565–1570.
43.
BoneRC, FisherCJJr, ClemmerTP, . Early methylprednisolone treatment for septic syndrome and the adult respiratory distress syndrome. Chest. 1987;92:1032–1036.
44.
WeigeltJA, NorcrossJF, BormanKR, SnyderWH. Early steroid therapy for respiratory failure. Arch Surg. 1985;120:536–540.
45.
SchonfeldSA, PloysongsangY, DiLisioR, . Fat embolism prophylaxis with corticosteroids. Ann Intern Med. 1983;99:438–443.
46.
IshizakaA, WuZ, StephensFE, . Attenuation of acute lung injury in septic guinea pigs by pentoxifylline. Am Rev Respir Dis. 1988;138:376–382.
47.
WewersMD, CasolaroMA, SellersSE, . Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema. N Engl J Med. 1987;316:1055–1062.
48.
TurrensJF, CrapoJD, FreemanBA. Protection against oxygen toxicity by intravenous injection of liposome-entrapped catalase and superoxide dismutase. J Clin Invest. 1984;73:87–95.
49.
MaunderRJ, WinnRK, GleisnerJM, HildebrandtJ, HarlanJM. Effect of intravenous catalase on the pulmonary vascular response to endotoxemia in goats. J Appl Physiol. 1988;64:697–704.
50.
BernardGR, LuchtWD, NiedermeyerME, . Effect of N-acetylcysteine on the pulmonary response to endotoxin in the awake sheep and upon in vitro granulocyte function. J Clin Invest. 1984;73:1772–1784.
51.
ZeiglerEJ, McCutchanJA, FiererJ, . Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli. N Engl J Med. 1982;307:1225–1230.
52.
BaumgartnerJD, McCutchanJA, ZieglerEJ, GlauserMP. Prevention of gram-negative shock and death in surgical patients by antibody to endotoxin core glycolipid. Lancet. 1985;2:59–63.
HarrisSK, BoneRC, RuthWE. Gastrointestinal hemorrhage in a RICU. Chest. 1977;72:301.
55.
AthertonST, WhiteDJ. Stomach as source of bacteria colonising respiratory tract during artificial ventilation. Lancet. 1978;4:968–969.
56.
duMoulinGC, PatersonDG, Hedley-WhyteJ, LisbonA.Aspiration of gastric bacteria in antacid-treated patients: A frequent cause of postoperative colonisation of the airway. Lancet. 1982;1:242–245.
57.
PingletonSK, HinthornDR, LiuC.Enteral nutrition in patients receiving mechanical ventilation: Multiple sources of tracheal colonization include the stomach. Am J Med. 1986;80:827–832.
58.
GiannellaR, BraitmanS, ZamcheckN.Gastric acid barrier to ingested microorganisms in man: Studies in vivo and in vitro. Gut. 1972;13:251–256.
59.
SneparR, PoporadGA, RomanoJM, KobasaWD, KayeD.Effect of cimetidine and antacid on gastric microbial flora. Infect Immun. 1982;36:518–524.
60.
DriksMR, CravenDE, CelliB, . Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. N Engl J Med. 1987;317:1376–1380.
61.
TrybaM.Risk of acute stress bleeding and nosocomial pneumonia in ventilated intensive care patients: Sucralfate versus antacids. Am J Med. 1987;83(Suppl 3B):117.
62.
TrybaM, Mantey-StiersF.Antibacterial activity of sucralfate in human gastric juice. Am J Med. 1987;83(Suppl 3B):125–127.
63.
StoutenbeekCP, van SaeneHKF, MirandaDR, . The effect of oropharyngeal decontamination using topical non-absorbable antibiotics on the incidence of nosocomial respiratory tract infections in multiple trauma patients. J Trauma. 1987;27:357.
64.
LedinghamIM, EastawayAT, McKayIC, AlcockSR, McDonaldJC, RamsayG.Triple regimen of selective decontamination of the digestive tract, systemic cefotaxime, and microbiological surveillance for prevention of acquired infection in intensive care. Lancet. 1988;1:785.
65.
van SaeneHKF, StoutenbeekCP, LawinP, LedinghamI McA (eds). Infection control in intensive care units by selective decontamination. Proceedings of the International Congress on Selective Decontamination held in Jersey, UK 1988. Update in Intensive Care and Emergency Medicine, Volume 7. Berlin: Springer-Verlag; 1989.
66.
FeeleyTW, du MoulinGC, Hedley-WhyteJ, . Aerosol polymyxin and pneumonia in seriously ill patients. N Engl J Med. 1975;293:471.